FDA Inspection 1004653 — Richard Reitman, MD

Richard Reitman, MD — FEI 3012938742

The FDA completed an inspection of Richard Reitman, MD on Feb 24, 2017 in Plano, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 24, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Plano, TX (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.